197 related articles for article (PubMed ID: 28440474)
1. Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation.
Ma C; Yin H; Zhong J; Zhang Y; Luo C; Che D; Fang Z; Li L; Qin S; Liang J; Qi W; Yang Z; Zhou T; Ma J; Yang X; Gao G
Int J Oncol; 2017 Jun; 50(6):2000-2010. PubMed ID: 28440474
[TBL] [Abstract][Full Text] [Related]
2. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.
Ma C; Luo C; Yin H; Zhang Y; Xiong W; Zhang T; Gao T; Wang X; Che D; Fang Z; Li L; Xie J; Huang M; Zhu L; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
Gastric Cancer; 2018 Jul; 21(4):617-631. PubMed ID: 29243194
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human kallistatin inhibits angiogenesis by blocking VEGF signaling pathway.
Huang KF; Yang HY; Xing YM; Lin JS; Diao Y
J Cell Biochem; 2014 Mar; 115(3):575-84. PubMed ID: 24129914
[TBL] [Abstract][Full Text] [Related]
4. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin.
Shiau AL; Teo ML; Chen SY; Wang CR; Hsieh JL; Chang MY; Chang CJ; Chao J; Chao L; Wu CL; Lee CH
BMC Cancer; 2010 May; 10():245. PubMed ID: 20509975
[TBL] [Abstract][Full Text] [Related]
6. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
[TBL] [Abstract][Full Text] [Related]
7. The Role of Methionine Aminopeptidase 2 in Lymphangiogenesis.
Esa R; Steinberg E; Dror D; Schwob O; Khajavi M; Maoz M; Kinarty Y; Inbal A; Zick A; Benny O
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708166
[TBL] [Abstract][Full Text] [Related]
8. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
9. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
10. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
[TBL] [Abstract][Full Text] [Related]
11. Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells.
Yang Y; Gao Z; Ma Y; Teng H; Liu Z; Wei H; Lu Y; Cheng X; Hou L; Zou X
Oncotarget; 2016 Jun; 7(25):38025-38035. PubMed ID: 27203545
[TBL] [Abstract][Full Text] [Related]
12. Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
Huang KF; Huang XP; Xiao GQ; Yang HY; Lin JS; Diao Y
Biomed Pharmacother; 2014 May; 68(4):455-61. PubMed ID: 24721321
[TBL] [Abstract][Full Text] [Related]
13. Delphinidin is a novel inhibitor of lymphangiogenesis but promotes mammary tumor growth and metastasis formation in syngeneic experimental rats.
Thiele W; Rothley M; Teller N; Jung N; Bulat B; Plaumann D; Vanderheiden S; Schmaus A; Cremers N; Göppert B; Dimmler A; Eschbach V; Quagliata L; Thaler S; Marko D; Bräse S; Sleeman JP
Carcinogenesis; 2013 Dec; 34(12):2804-13. PubMed ID: 23975834
[TBL] [Abstract][Full Text] [Related]
14. The Suppression of Kallistatin on High-Glucose-Induced Proliferation of Retinal Endothelial Cells in Diabetic Retinopathy.
Xing Q; Zhang G; Kang L; Wu J; Chen H; Liu G; Zhu R; Guan H; Lu P
Ophthalmic Res; 2017; 57(3):141-149. PubMed ID: 27537690
[TBL] [Abstract][Full Text] [Related]
15. [Plasmid-mediated expression of kallistatin and its biological activity in lung cancer related cells].
Wang NQ; Zou J; Diao Y
Yao Xue Xue Bao; 2013 Mar; 48(3):359-65. PubMed ID: 23724648
[TBL] [Abstract][Full Text] [Related]
16. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
Hwang-Bo J; Yoo KH; Park JH; Jeong HS; Chung IS
Int J Cancer; 2012 Jul; 131(2):298-309. PubMed ID: 21823121
[TBL] [Abstract][Full Text] [Related]
17. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.
Nandi P; Girish GV; Majumder M; Xin X; Tutunea-Fatan E; Lala PK
BMC Cancer; 2017 Jan; 17(1):11. PubMed ID: 28056899
[TBL] [Abstract][Full Text] [Related]
18. Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells.
Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Ngiwsara L; Svasti J; Koizumi K
Vasc Med; 2018 Jun; 23(3):201-211. PubMed ID: 29629844
[TBL] [Abstract][Full Text] [Related]
19. Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells.
Tai HC; Lee TH; Tang CH; Chen LP; Chen WC; Lee MS; Chen PC; Lin CY; Chi CW; Chen YJ; Lai CT; Chen SS; Liao KW; Lee CH; Wang SW
Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 30959907
[TBL] [Abstract][Full Text] [Related]
20. Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
Wang C; Xu S; Tian Y; Ju A; Hou Q; Liu J; Fu Y; Luo Y
Neoplasia; 2019 Apr; 21(4):413-427. PubMed ID: 30925417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
